A combination of omega-3 fatty acids, folic acid and B-group vitamins is superior at lowering homocysteine than omega-3 alone: A meta-analysis

Nutrition Research

Volumn 36, Issue 6, 2016, Pages 499-508

  Dawson, Samantha Loren ^a   Bowe, Steven John ^a   Crowe, Timothy Charles ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

B group Vitamins; Folic acid; Homocysteine; Meta analysis; Omega 3 PUFAs

Indexed keywords

DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; VITAMIN B GROUP; VITAMIN B COMPLEX;

AMINO ACID ANALYSIS; DATA ANALYSIS; DATA EXTRACTION; FOLLOW UP; HEALTH STATUS; HUMAN; PRIORITY JOURNAL; PUBLISHING; REVIEW; RISK; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ANIMAL; ANIMAL MODEL; BLOOD; COMBINATION DRUG THERAPY; DIETARY SUPPLEMENT; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY;

ANIMALS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; FOLIC ACID; HOMOCYSTEINE; HUMANS; MODELS, ANIMAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; VITAMIN B COMPLEX;

EID: 84964331065     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.03.010     Document Type: Review

References (46)

1. Finkelstein J.D. Methionine metabolism in mammals. J Nutr Biochem 1990, 1:228-237.
2. Malinow M.R., Bostom A.G., Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: A Statement for Healthcare Professionals from the Nutrition Committee. Am Heart Assoc Circ 1999, 99:178-182.
3. Gjesdal C.G., Vollset S.E., Ueland P.M., Refsum H., Drevon C.A., Gjessing H.K., et al. Plasma total homocysteine level and bone mineral density: the Hordaland homocysteine study. Arch Intern Med 2006, 166:88-94.
4. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
5. Kivipelto M., Annerbo S., Hultdin J., Backman L., Viitanen M., Fratiglioni L., et al. Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol 2009, 16:808-813.
6. Watkins S.M., Lin T.Y., Davis R.M., Ching J.R., DePeters E.J., Halpern G.M., et al. Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or alpha-linolenic acids. Lipids 2001, 36:247-254.
7. Huang T., Wahlqvist M.L., Li D. Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism. Nutr J 2012, 11:6.
8. Pooya S., Jalali M.D., Jazayery A.D., Saedisomeolia A., Eshraghian M.R., Toorang F. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2010, 20:326-331.
9. Djalali M., Pouya S., Djazayeri A., Eshraghian M., Turang F., Ramezani F. The effects of omega-3 fatty acids on blood homocysteine level in type 2 diabetic patients. ARYA Atheroscler 2008, 3:211-214.
10. Beavers K.M., Beavers D.P., Bowden R.G., Wilson R.L., Gentile M. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients. Nephrology 2008, 13:284-288.
11. Grundt H., Nilsen D.W.T., Mansoor M.A., Hetland, Oslash, yvind, et al. Reduction in Homocysteine by n-3 Polyunsaturated Fatty Acids after 1 Year in a Randomised Double-Blind Study following an Acute Myocardial Infarction: No Effect on Endothelial Adhesion Properties. Pathophysiol Haemost Thromb 2003, 33:88-95.
12. Zeman M., Zak A., Vecka M., Tvrzicka E., Pisarikova A., Stankova B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem 2006, 17:379-384.
13. Rasmussen L.E., Svensson M., Jorgensen K.A., Schmidt E.B., Christensen J.H. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease. Nutr Res 2010, 30:535-540.
14. Piolot A., Blache D., Boulet L., Fortin L.J., Dubreuil D., Marcoux C., et al. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med 2003, 141:41-49.
15. Huang T., Zheng J., Chen Y., Yang B., Wahlqvist M.L., Li D. High consumption of Ω-3 polyunsaturated fatty acids decrease plasma homocysteine: a meta-analysis of randomized, placebo-controlled trials. Nutrition 2011, 27:863-867.
16. Benito P., Caballero J., Moreno J., Gutierrez-Alcantara C., Munoz C., Rojo G., et al. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 2006, 25:581-587.
17. Carrero J.J., López-Huertas E., Salmerón L.M., Ramos V.E., Baró L., Ros E. Simvastatin and supplementation with ω-3 polyunsaturated fatty acids and vitamins improves claudication distance in a randomized PILOT study in patients with peripheral vascular disease. Nutr Res 2006, 26:637-643.
18. Carrero J.J., Lopez-Huertas E., Salmeron L.M., Baro L., Ros E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr 2005, 135:1393-1399.
19. Carrero J.J., Fonolla J., Marti J., Jimenez J., Boza J., Lopez-Huertas E. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 Year decreases plasma C-reactive protein and Reduces Coronary heart disease risk factors in Male patients in a Cardiac Rehabilitation Program1. J Nutr 2007, 137:384-390.
20. Miller E.R., Juraschek S., Pastor-Barriuso R., Bazzano L.A., Appel L.J., Guallar E. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol 2010, 106:517-527.
21. Martí-Carvajal A., Solà I., Lathyris D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2015.
22. Kuratko C.N., Nolan C.C., Salem N. Long-chain omega-3 fatty acids and cardiovascular health. Nutrafoods 2014, 13:49-60.
23. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
24. Review Manager (RevMan). Version 5.3 ed. Copenhagen 2014, The Cochrane Collaboration, The Nordic Cochrane Centre.
25. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008, 61:991-996.
26. Cochran W.G. The combination of estimates from different Experiments. Biometrics 1954, 10:101-129.
27. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
28. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
29. Viechtbauer W. Conducting Meta-analyses in R with the metafor package. J Stat Softw 2010, 36:1-48.
30. Earnest C.P., Kupper J.S., Thompson A.M., Guo W., Church T. Complementary effects of multivitamin and omega-3 fatty acid supplementation on indices of cardiovascular health in individuals with elevated homocysteine. Int J Vitam Nutr Res 2012, 82:41-52.
31. Galan P., Kesse-Guyot E., Czernichow S., Briancon S., Blacher J., Hercberg S., et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010, 341:c6273.
32. Garcia-Alonso F.J., Jorge-Vidal V., Ros G., Periago M.J. Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women. Eur J Nutr 2012, 51:415-424.
33. Fonolla J., Lopez-Huertas E., Machado F.J., Molina D., Alvarez I., Marmol E., et al. Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and nutritional status in human volunteers. Nutrition 2009, 25:408-414.
34. Bowden R.G., Wilson R.L., Deike E., Gentile M. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 2009, 24:508-512.
35. Tayyebi-Khosroshahi H., Dehgan R., Habibi A., Safaian A., Panahi F., Estakhri R., et al. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis 2010, 4.
36. Brude I.R., Finstad H.S., Seljeflot I., Drevon C.A., Solvoll K., Sandstad B., et al. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. European journal of clinical investigation. Eur J Clin Invest 1999, 29:100-108.
37. Grundt H., Nilsen D.W., Hetland O., Mansoor M.A., Aarsland T., Woie L. Atherothrombogenic Risk Modulation by n-3 Fatty Acids Was not Associated with Changes in Homocysteine in Subjects with Combined Hyperlipidaemia. Thromb Haemost 1999, 81:561-565.
38. Derosa G., Maffioli P., D'Angelo A., Salvadeo S.A.T., Ferrari I., Fogari E., et al. Effects of long chain ω-3 fatty acids on metalloproteinases and their inhibitors in combined dyslipidemia patients. Expert Opin Pharmacother 2009, 10:1239-1247.
39. Bruce W.R., Cirocco M., Giacca A., Kim Y.I., Marcon N., Minkin S. A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation. Br J Cancer 2005, 93:639-646.
40. Durand P., Prost M., Loreau N., Lussier-Cacan S., Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001, 81:645-672.
41. Bostom A.G., Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997, 52:10-20.
42. Ratnam S., Wijekoon E.P., Hall B., Garrow T.A., Brosnan M.E., Brosnan J.T. Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver. Am J Physiol Endocrinol Metab 2006, 290:E933-E939.
43. Huang T., Wahlqvist M.L., Li D. Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism. Nutrition 2010, 26:112-119.
44. Obeid R., Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009, 583:1215-1225.
45. Mallampalli R.K., Salome R.G., Spector A.A. Regulation of CTP:choline-phosphate cytidylyltransferase by polyunsaturated n-3 fatty acids. Am J Physiol 1994, 267:L641-L648.
46. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202.